AbbVie appoints new Chief Scientific Officer
European Pharmaceutical Review
JULY 11, 2024
He has the right vision, skills and experience to lead our R&D organisation,” commented Rob Michael, Chief Executive Officer, AbbVie. “As AbbVie’s Chief Scientific Officer, Dr Thakkar will continue to build momentum across discovery and all stages of development to fully realise the potential of our diverse pipeline.
Let's personalize your content